What is MEDP's five-year median EV/EBITDA?

24.8x. Half of MEDP's weekly readings over the last five years were higher and half were lower. This page has 504 weekly readings, from Feb 27, 2017 to Oct 19, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares MEDP only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Medpace Holdings Inc (MEDP) valuation history

Health Care

$669.20

Latest weekly close · Market cap $19.0B

Above its usual range

As of Oct 24, 2026

MEDP's EV/EBITDA of 28.8x is higher than 79% of its weekly readings over the last five years.

Weekly EV/EBITDA with its 5-year range

EV/EBITDA each weekMiddle half of the last 5 years5-year median 24.8×

5-year median: 24.8×
10-year median: 23.2×
5-year low to high: 17.9×–36.9×
Versus 5-year median: +16%

EV/EBITDA

79thpercentile

of its weekly readings over the last five years

Above its usual range

Growth, last 12 months vs the year before

Revenue: +20%slowing
EPS: +26%

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading

EV/EBITDA at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

MEDP EV/EBITDA at each year-end
Year-end	EV/EBITDA	5-year percentile
Dec 29, 2025	30.2×	71
Dec 30, 2024	23.4×	31
Dec 25, 2023	27.5×	72
Dec 26, 2022	24.9×	65
Dec 27, 2021	35.3×	97
Dec 28, 2020	30.1×	97
Dec 30, 2019	20.4×	93
Dec 31, 2018	16.1×	71
Dec 25, 2017	14.2×	Too little history

Health Care peers on EV/EBITDA

Each percentile compares a stock with its own last five years.

Compare MEDP with peers

Health Care peers of MEDP on EV/EBITDA
Stock	EV/EBITDA	Versus its own history	5-year percentile
AAgilent Technologies	26.9×	Historically high	91
AVTRAvantor Inc	128.7×	Historically high	100
BIOBio-Rad Laboratories Inc	n/a	Not ranked	n/a, not ranked
BRKRBruker Corp	52.1×	Historically high	97
CRLCharles River Laboratories	48.3×	Historically high	100

Appears in

Sector: Health Care
Screens: Stocks with Low P/E Ratios and Steady Revenue Growth
Stocks Below Their 5-Year Median P/E
Stocks Near Their Lowest P/E Ratios in 5 Years

Screen Health Care stocks the same way

Research on MEDP

No articles about MEDP yet. How valuation percentiles work

Loading peers and related research…

About this history

What is MEDP's current EV/EBITDA?: MEDP's EV/EBITDA of 28.8x is higher than 79% of its weekly readings over the last five years.
What is MEDP's five-year median EV/EBITDA?: 24.8x. Half of MEDP's weekly readings over the last five years were higher and half were lower. This page has 504 weekly readings, from Feb 27, 2017 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares MEDP only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.